Post-earnings recap
Reported
Tue, Jul 24, 2012
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
Biogen's earnings report shows a positive surprise in EPS, which contributed to a slight increase in stock price. The lack of revenue data and guidance may leave investors cautious, but the EPS beat indicates some operational strength. Overall, the stock's modest rise reflects a generally favorable reception of the earnings results.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.61 | N/A | +3.34% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the EPS results, highlighting their commitment to shareholder value. However, no specific guidance was provided for future quarters.
We are pleased with our EPS performance this quarter.
Our focus remains on delivering value to our shareholders.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—